Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study. (Q64927892)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 March 2018

Language	Label	Description	Also known as
English	Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.	scientific article published on 25 March 2018

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

Julio Rosenstock

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Aniko Somogyi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Hui Wang

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Elise Hardy

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

25 March 2018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1602-1614

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone long-acting formulation in the treatment of alcohol dependence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of Self-Reported Weight Change and Quality of Life, and Exercise and Weight Management Behaviors Among Adults with Type 2 Diabetes Mellitus: The SHIELD Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised c

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2. Classification and Diagnosis of Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

8. Pharmacologic Approaches to Glycemic Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29473704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/DOM.13266

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29473704%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64927892&oldid=1563437866"